Rheumatoid arthritis trials in Romania

In Romania 9 Also abroad 351

9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Where
Bucharest, Cluj-Napoca
Age
18 years to 75 years
People
21 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07363590 · EU 2025-523412-36-00
Phase 1Taking people
A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis
Where
Bucharest, Cluj-Napoca
Age
18 years to 70 years
People
36 worldwide
Run by
Jade Biosciences, Inc.
See details and how to joinNCT07533955
Phase 1Taking people
Phase 1 Single Dose Study of JADE201 in Participants with Rheumatoid Arthritis
Where
Bucharest, Cluj-Napoca
Age
18 years and over
People
24 worldwide
Run by
Jade Biosciences Inc.
See details and how to join2025-524746-96-00 · EU 2025-524746-96-00
Phase 1Taking people
A First-in-Human, Open-label, Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of NBIM-1008 in Patients with Rheumatoid Arthritis
Where
Bucharest, Cluj-Napoca
Age
18 years to 64 years
People
15 worldwide
Run by
Neurocrine Biosciences Inc.
See details and how to join2025-525113-22-00 · EU 2025-525113-22-00
Phase 2Taking people
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Where
Bucharest
Age
18 years and over
People
90 worldwide
Run by
Artiva Biotherapeutics, Inc.
See details and how to joinNCT06991114 · EU 2025-520461-41-00
Phase 1Taking people
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Where
Bucharest, Cluj-Napoca
Age
18 years and over
People
125 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00
Phase 1Taking people
A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis
Where
Bucharest, Cluj-Napoca
Age
18 years to 60 years
People
27 worldwide
Run by
SciRhom GmbH
See details and how to joinNCT07433335 · EU 2025-523678-17-00
Phase 1Taking people
A phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid arthritis (RA)
Where
Bucharest, Cluj-Napoca
Age
18 years and over
People
40 worldwide
Run by
Novartis Pharma AG
See details and how to join2024-520196-27-00 · EU 2024-520196-27-00
Phase 4Taking people
MethMax trial
Where
Bucharest
Age
18 years and over
People
212 worldwide
Run by
Medical University of Vienna
See details and how to join2023-507714-27-00 · EU 2023-507714-27-00